Literature DB >> 12843156

Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young females.

Angelo Tremblay1, Luigi Bouchard, Claude Bouchard, Jean-Pierre Després, Vicky Drapeau, Louis Pérusse.   

Abstract

Male and female preadolescents and adolescents who participated in phase 1 of the Québec Family Study, and who were retested about 12 yr later, were recruited and subdivided on the basis of a genetic variant within the intron 2 of the glucocorticoid receptor (GRL IVS2-BclI). The increase in sc adiposity over the 12-yr follow-up period in the 4.5/2.3 genotype female subgroup was more than twice that observed in the 4.5/4.5 and the 2.3/2.3 genotype subgroups (P < 0.01). The statistical significance of this difference was essentially unchanged after adjusting for changes, over time, in percent dietary energy as fat, alcohol consumption, and participation in vigorous physical activity. In male subjects, the same trend was found, but it did not reach statistical significance. In conclusion, this study suggests that a significant interaction effect exists between variation in the glucocorticoid receptor gene and body fat gain in female subjects experiencing the transition between adolescence and adulthood. Further research will, however, be necessary to characterize the lifestyle factors promoting fat accumulation, over time, among genetically susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843156     DOI: 10.1210/jc.2002-021521

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency.

Authors:  Ricardo P P Moreira; Larissa G Gomes; Berenice B Mendonca; Tânia A S S Bachega
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

3.  Association Between N363S and BclI Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Side Effects During Childhood Acute Lymphoblastic Leukemia Treatment.

Authors:  Meriç Kaymak Cihan; Halil Gürhan Karabulut; Nüket Yürür Kutlay; Hatice Ilgın Ruhi; Ajlan Tükün; Lale Olcay
Journal:  Turk J Haematol       Date:  2017-02-09       Impact factor: 1.831

4.  A 646C > G (rs41423247) polymorphism of the glucocorticoid receptor as a risk factor for hyperglycaemia diagnosed in pregnancy-data from an observational study.

Authors:  Agnieszka Zawiejska; Anna Bogacz; Rafał Iciek; Agnieszka Lewicka-Rabska; Maciej Brązert; Przemysław Mikołajczak; Jacek Brązert
Journal:  Acta Diabetol       Date:  2021-10-14       Impact factor: 4.280

5.  Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease.

Authors:  Ricardo P P Moreira; Tânia A S S Bachega; Márcio C Machado; Berenice B Mendonca; Marcello D Bronstein; Maria Candida B Villares Fragoso
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

6.  The body politic: the relationship between stigma and obesity-associated disease.

Authors:  Peter Muennig
Journal:  BMC Public Health       Date:  2008-04-21       Impact factor: 3.295

7.  Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population.

Authors:  Yu-Xiang Yan; Jing Dong; Li-Juan Wu; Shuang Shao; Jie Zhang; Ling Zhang; Wei Wang; Yan He; You-Qin Liu
Journal:  J Epidemiol       Date:  2013-07-27       Impact factor: 3.211

8.  Ganoderma lucidum Extract Reduces Insulin Resistance by Enhancing AMPK Activation in High-Fat Diet-Induced Obese Mice.

Authors:  Hyeon A Lee; Jae-Han Cho; Qonita Afinanisa; Gi-Hong An; Jae-Gu Han; Hyo Jeung Kang; Seong Ho Choi; Hyun-A Seong
Journal:  Nutrients       Date:  2020-10-30       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.